Financial Gravity Asset Management, Inc. Inovio Pharmaceuticals, Inc. Transaction History

Financial Gravity Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$0.38 - $0.58 $6 - $9	17 New	17 $0
Q2 2023 Aug 08, 2023	SELL	$0.39 - $0.94 $0 - $0	-1 Closed	0 $17,000
Q1 2023 May 12, 2023	SELL	$0.79 - $1.91 $0 - $1	-1 Reduced 50.0%	1 $15,000
Q4 2022 Feb 15, 2023	SELL	$1.41 - $2.5 $14 - $25	-10 Reduced 83.33%	2 $60,000
Q2 2022 Aug 05, 2022	SELL	$1.44 - $3.98 $17 - $47	-12 Reduced 50.0%	12 $31,000
Q1 2022 May 13, 2022	SELL	$2.97 - $5.2 $17 - $31	-6 Reduced 20.0%	24 $64,000
Q4 2021 Feb 11, 2022	BUY	$4.99 - $7.46 $59 - $89	12 Added 66.67%	30 $88,000
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $128 - $174	18 New	18 $7,000
Q4 2019 Feb 28, 2020	SELL	$1.97 - $3.72 $78 - $148	-40 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$3.92 - $5.58 $156 - $223	40 New	40 $0

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $494M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Financial Gravity Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Gravity Asset Management, Inc. with notifications on news.